1. Home
  2. OTLK vs AP Comparison

OTLK vs AP Comparison

Compare OTLK & AP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTLK
  • AP
  • Stock Information
  • Founded
  • OTLK 2010
  • AP 1929
  • Country
  • OTLK United States
  • AP United States
  • Employees
  • OTLK N/A
  • AP N/A
  • Industry
  • OTLK Biotechnology: Biological Products (No Diagnostic Substances)
  • AP Fluid Controls
  • Sector
  • OTLK Health Care
  • AP Industrials
  • Exchange
  • OTLK Nasdaq
  • AP Nasdaq
  • Market Cap
  • OTLK 48.3M
  • AP 54.7M
  • IPO Year
  • OTLK 2016
  • AP N/A
  • Fundamental
  • Price
  • OTLK $1.77
  • AP $3.47
  • Analyst Decision
  • OTLK Strong Buy
  • AP
  • Analyst Count
  • OTLK 5
  • AP 0
  • Target Price
  • OTLK $10.20
  • AP N/A
  • AVG Volume (30 Days)
  • OTLK 689.4K
  • AP 78.8K
  • Earning Date
  • OTLK 05-15-2025
  • AP 05-12-2025
  • Dividend Yield
  • OTLK N/A
  • AP N/A
  • EPS Growth
  • OTLK N/A
  • AP N/A
  • EPS
  • OTLK 0.83
  • AP 0.22
  • Revenue
  • OTLK N/A
  • AP $412,355,000.00
  • Revenue This Year
  • OTLK N/A
  • AP N/A
  • Revenue Next Year
  • OTLK $288.46
  • AP N/A
  • P/E Ratio
  • OTLK $2.12
  • AP $13.97
  • Revenue Growth
  • OTLK N/A
  • AP N/A
  • 52 Week Low
  • OTLK $0.87
  • AP $0.74
  • 52 Week High
  • OTLK $9.25
  • AP $3.59
  • Technical
  • Relative Strength Index (RSI)
  • OTLK 57.64
  • AP 70.23
  • Support Level
  • OTLK $1.55
  • AP $2.94
  • Resistance Level
  • OTLK $1.90
  • AP $3.13
  • Average True Range (ATR)
  • OTLK 0.18
  • AP 0.31
  • MACD
  • OTLK 0.01
  • AP 0.04
  • Stochastic Oscillator
  • OTLK 53.10
  • AP 91.50

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

About AP Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.

Share on Social Networks: